Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Montigiani
S. Montigiani
Novartis
Virology
Medicine
Diabetes mellitus
PEG ratio
Ribavirin
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Erratum: (Journal of Viral Hepatitis)
2014
Journal of Viral Hepatitis
F Oliveri
S. Madonia
Antonio Craxì
Massimo Colombo
A. Muzzi
P. Ciccorossi
B. Coco
S. Montigiani
P. Rinella
S. Fargion
Show All
Source
Cite
Save
Citations (0)
602 THE CANDIDATE HCV E1E2MF59 VACCINE IS SAFE IN CHRONIC HEPATITIS C PATIENTS AND ACCELLERATES THE SECOND PHASE VIRAL DECLINE UPON PRIMARY RESPONSE TO PEG-INTERFERON-2A/RIBAVIRIN THERAPY
2009
Journal of Hepatology
P. Colombatto
Maurizia Rossana Brunetto
A.M. Maina
V. Romagnoli
A. Craxì
P.L. Almasio
S. Madonia
M.G. Rumi
M. Colombo
S. Fargion
A. Ascione
G. Pinzello
Mario U. Mondelli
A. Muzzi
F.B. Bianchi
Vincenzo Barnaba
M Sarracino
Rino Rappuoli
Domenico Rosa
S. Montigiani
Sergio Abrignani
Michael Houghton
Ferruccio Bonino
Show All
Source
Cite
Save
Citations (1)
The candidate HCV E1E2MF59 vaccine enhances 2nd phase viral decline in responders to PEG-IFN/ribavirin
2009
Digestive and Liver Disease
P. Colombatto
Maurizia Rossana Brunetto
A.M. Maina
V. Romagnoli
A. Craxì
P.L. Almasio
S. Madonia
M.G. Rumi
M. Colombo
S. Fargion
A. Ascione
G. Pinzello
Mario U. Mondelli
A. Muzzi
F.B. Bianchi
Vincenzo Barnaba
M. Sarracino
Rino Rappuoli
Domenico Rosa
S. Montigiani
Sergio Abrignani
Michael Houghton
Ferruccio Bonino
Show All
Source
Cite
Save
Citations (0)
1